Literature DB >> 12752568

Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease.

A Miller1, L K Brown, G M Pastores, R J Desnick.   

Abstract

Pulmonary disease is a well-known complication of Type 1 Gaucher disease (GD), although its incidence is not well established and its severity varies. The purpose of this study was to determine the frequency and extent of pulmonary involvement in patients with GD. Pulmonary involvement was assessed by history, physical examination and chest radiograph in 150 consecutive patients with Type 1 GD presenting at a specialized center for genetic diseases. Five patients were noted to have clinical evidence of pulmonary involvement. Full pulmonary function tests were performed in these five patients and in an additional 13 patients randomly selected from the remaining 145. Many of the 18 patients also underwent radionuclide body imaging with 67 Gallium citrate and 111Indium-tagged leucocyte scans, as well as incremental cardiorespiratory exercise tests. Lung biopsies were available in two patients with lung disease, and a second examination of lung tissue was performed in one of these two patients post-mortem. Clinical lung disease was detected in five patients. All five had dyspnea, diffuse infiltrates, restrictive impairment and low single breath CO diffusing capacity (DLCOSB). Two of these patients underwent exercise testing and showed abnormalities consistent with lung disease (ventilatory limitation, excessive ventilation and increased dead space) as well as decreased VO2 max. and anaerobic threshold (AT). In contrast, in the other 13 patients, physical examination, chest radiographs and pulmonary function were normal (except for a low DLCOSB in one patient). Responses on exercise testing (performed in six of the 13 patients) were consistent with a circulatory impairment (decreased VO2 max. and AT). Our study found that <5% of patients with Type 1 GD have clinical interstitial lung disease. In addition, we found that some patients, without evident lung involvement, may experience limitations in physical exertion and are easily fatigued; this is attributable to impaired circulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752568     DOI: 10.1034/j.1399-0004.2003.00060.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 2.  [Interstitial processes of the lungs in childhood].

Authors:  H Popper
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

Review 3.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

Review 4.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

5.  Pulmonary Involvement Responsive to Enzyme Replacement Therapy in an Elderly Patient with Gaucher Disease.

Authors:  Dylan Vellas; Baptiste Gramont; Rémi Grange; Pascal Cathébras
Journal:  Eur J Case Rep Intern Med       Date:  2021-09-08

6.  Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease.

Authors:  Fu-Shiuan Lee; Hsiu-Ju Yen; Dau-Ming Niu; Giun-Yi Hung; Chih-Ying Lee; Yi-Chen Yeh; Paul Chih-Hsueh Chen; Sheng-Kai Chang; Chia-Feng Yang
Journal:  Mol Genet Metab Rep       Date:  2020-10-20

Review 7.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

8.  Randomized, controlled trial of miglustat in Gaucher's disease type 3.

Authors:  Raphael Schiffmann; Edmond J Fitzgibbon; Chris Harris; Catherine DeVile; Elin H Davies; Larry Abel; Ivo N van Schaik; William Benko; Margaret Timmons; Markus Ries; Ashok Vellodi
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

Review 9.  Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.

Authors:  Hiroshi Kitazawa; Shigeo Kure
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-10-11

10.  Cardiopulmonary assessment of patients diagnosed with Gaucher's disease type I.

Authors:  Marija Bjelobrk; Milan Lakocevic; Svetozar Damjanovic; Milan Petakov; Milan Petrovic; Zoran Bosnic; Ross Arena; Dejana Popovic
Journal:  Mol Genet Genomic Med       Date:  2021-07-18       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.